Epidemiological impact of a genital herpes type 2 vaccine for young females.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3469571)

Published in PLoS One on October 11, 2012

Authors

Yijun Lou1, Redouane Qesmi, Qian Wang, Marc Steben, Jianhong Wu, Jane M Heffernan

Author Affiliations

1: Mathematics and Statistics, York University, Toronto, Ontario, Canada.

Articles cited by this

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (2006) 10.56

Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med (1997) 7.59

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA (2006) 7.46

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis (2001) 6.35

Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med (2002) 6.23

Perspectives on the basic reproductive ratio. J R Soc Interface (2005) 5.34

A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol (2008) 5.11

Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med (2004) 5.04

Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis (2008) 4.05

Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl (1990) 4.02

Risk factors for the sexual transmission of genital herpes. Ann Intern Med (1992) 3.89

Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma. J Clin Oncol (2009) 3.80

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med (1991) 3.19

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet (1994) 2.53

The 2006-2010 National Survey of Family Growth: sample design and analysis of a continuous survey. Vital Health Stat 2 (2010) 2.41

The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med (2005) 2.34

Predicting and preventing the emergence of antiviral drug resistance in HSV-2. Nat Med (1998) 2.07

Genital herpes infection: a review. Int J Epidemiol (1997) 1.84

Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model. Sci Transl Med (2009) 1.60

Genital herpes: gynaecological aspects. J Obstet Gynaecol Can (2008) 1.40

Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol (2001) 1.30

Sexual behavior among U.S. high school students, 1990-1995. Fam Plann Perspect (1998) 1.30

Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics. J Infect Dis (2004) 1.29

Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sex Transm Dis (2008) 1.06

HIV immunization: acceptability and anticipated effects on sexual behavior among adolescents. J Adolesc Health (1999) 1.04

Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol (2002) 1.01

The potential epidemiological impact of a genital herpes vaccine for women. Sex Transm Infect (2004) 1.00

Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis (2001) 0.97

Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Transm Dis (2003) 0.88

Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2. Sex Transm Dis (2010) 0.88

Transmission of herpes simplex virus Type 2 among factory workers in Ethiopia. J Infect Dis (2004) 0.86

Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty. Bull Math Biol (2009) 0.86

Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines. J Infect Dis (2005) 0.83

Human papillomavirus vaccines: Why the time is right to implement immunization and surveillance programs in Canada. Can J Infect Dis Med Microbiol (2008) 0.79

Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination? BMC Public Health (2008) 0.79

Articles by these authors

(truncated to the top 100)

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med (2007) 12.17

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09

Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ (2009) 4.44

Ballistic carbon nanotube field-effect transistors. Nature (2003) 4.35

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst (2010) 4.20

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis (2009) 3.55

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ (2010) 3.41

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet (2007) 3.10

Fluorescence visualization of newly synthesized proteins in mammalian cells. Angew Chem Int Ed Engl (2006) 2.96

Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis (2009) 2.92

Severe fever with thrombocytopenia syndrome virus, Shandong Province, China. Emerg Infect Dis (2012) 2.77

Polarization-controlled tunable directional coupling of surface plasmon polaritons. Science (2013) 2.73

Improvement of Fat Graft Survival with Autologous Bone Marrow Aspirate and Bone Marrow Concentrate: A One-Step Method. Plast Reconstr Surg (2016) 2.59

A fluorogenic 1,3-dipolar cycloaddition reaction of 3-azidocoumarins and acetylenes. Org Lett (2004) 2.57

Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation (2006) 2.50

Cilium-generated signaling and cilia-related disorders. Lab Invest (2005) 2.42

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) (2009) 2.42

Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci (2004) 2.40

GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data. Bioinformatics (2012) 2.21

High-kappa dielectrics for advanced carbon-nanotube transistors and logic gates. Nat Mater (2002) 2.18

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine (2008) 2.09

Modeling elastic properties in finite-element analysis: how much precision is needed to produce an accurate model? Anat Rec A Discov Mol Cell Evol Biol (2005) 2.01

An investigation of the mechanisms of electronic sensing of protein adsorption on carbon nanotube devices. J Am Chem Soc (2004) 1.98

Effect of oral ALA supplementation on oxidative stress and insulin sensitivity among overweight/obese adults: a double-blinded, randomized, controlled, cross-over intervention trial. Int J Cardiol (2012) 1.98

OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY. Retina (2016) 1.93

Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell (2007) 1.90

Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J Neurosci (2005) 1.89

Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors. Clin Cancer Res (2010) 1.89

Activation of RalA is required for insulin-stimulated Glut4 trafficking to the plasma membrane via the exocyst and the motor protein Myo1c. Dev Cell (2007) 1.88

Electron transport in very clean, as-grown suspended carbon nanotubes. Nat Mater (2005) 1.86

Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial. J Clin Oncol (2012) 1.84

Topoisomerase IIIalpha and Bloom's helicase can resolve a mobile double Holliday junction substrate through convergent branch migration. Proc Natl Acad Sci U S A (2006) 1.83

Simple models for containment of a pandemic. J R Soc Interface (2006) 1.78

Selective dye-labeling of newly synthesized proteins in bacterial cells. J Am Chem Soc (2005) 1.77

Cilia and flagella revealed: from flagellar assembly in Chlamydomonas to human obesity disorders. Cell (2004) 1.76

ABSORB: Atlas Building by Self-organized Registration and Bundling. Neuroimage (2010) 1.75

An aurora kinase is essential for flagellar disassembly in Chlamydomonas. Dev Cell (2004) 1.75

Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev (2011) 1.74

Thermal conductance of an individual single-wall carbon nanotube above room temperature. Nano Lett (2006) 1.73

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood (2010) 1.72

Population-wide emergence of antiviral resistance during pandemic influenza. PLoS One (2008) 1.71

Modelling strategies for controlling SARS outbreaks. Proc Biol Sci (2004) 1.71

Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics (2006) 1.71

Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res (2009) 1.70

High-field quasiballistic transport in short carbon nanotubes. Phys Rev Lett (2004) 1.68

The feeding biomechanics and dietary ecology of Australopithecus africanus. Proc Natl Acad Sci U S A (2009) 1.66

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin (2009) 1.66

A comprehensive view of nuclear receptor cancer cistromes. Cancer Res (2011) 1.64

Self-directed self-assembly of nanoparticle/copolymer mixtures. Nature (2005) 1.62

The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest (2002) 1.56

Clinical presentation and management of mTOR inhibitor-associated stomatitis. Oral Oncol (2011) 1.54

Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology (2005) 1.53

A novel Crumbs3 isoform regulates cell division and ciliogenesis via importin beta interactions. J Cell Biol (2007) 1.53

Hydrogen-rich saline reduces the oxidative stress and relieves the severity of trauma-induced acute pancreatitis in rats. J Trauma Acute Care Surg (2012) 1.50

Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis (2006) 1.49

Emergence of drug resistance: implications for antiviral control of pandemic influenza. Proc Biol Sci (2007) 1.49

The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs. J Biol Chem (2010) 1.48

An experimental design to study adipocyte stem cells for reconstruction of calvarial defects. J Craniofac Surg (2009) 1.47

Genome-scale transcriptome analysis of the desert poplar, Populus euphratica. Tree Physiol (2011) 1.47

Prioritizing risk pathways: a novel association approach to searching for disease pathways fusing SNPs and pathways. Bioinformatics (2008) 1.46

A cone-beam computed tomography study of maxillary first permanent molar root and canal morphology in a Chinese population. J Endod (2010) 1.45

Surface modification of tobacco mosaic virus with "click" chemistry. Chembiochem (2008) 1.43

Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res (2009) 1.42

Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. Biomacromolecules (2003) 1.42

Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol (2004) 1.41

Associations of Anogenital Low-Risk Human Papillomavirus Infection With Cancer and Acquisition of HIV. Sex Transm Dis (2015) 1.40

Co-delivery of HIV-1 entry inhibitor and nonnucleoside reverse transcriptase inhibitor shuttled by nanoparticles: cocktail therapeutic strategy for antiviral therapy. AIDS (2016) 1.40

Carbon nanotube DNA sensor and sensing mechanism. Nano Lett (2006) 1.39

The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol (2008) 1.38

Preparation of superhydrophobic polymeric film on aluminum plates by electrochemical polymerization. Molecules (2009) 1.38

Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. Ann Neurol (2012) 1.37

SharpMean: groupwise registration guided by sharp mean image and tree-based registration. Neuroimage (2011) 1.37

Dual strategies for peptidoglycan discrimination by peptidoglycan recognition proteins (PGRPs). Proc Natl Acad Sci U S A (2006) 1.35

The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay. Hum Vaccin (2011) 1.35

Astrocyte-derived ATP modulates depressive-like behaviors. Nat Med (2013) 1.35

Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev (2010) 1.34

Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis (2013) 1.33

Electromechanical properties of metallic, quasimetallic, and semiconducting carbon nanotubes under stretching. Phys Rev Lett (2003) 1.32

Genomic insights into salt adaptation in a desert poplar. Nat Commun (2013) 1.30

A sequence-based genetic linkage map as a reference for Brassica rapa pseudochromosome assembly. BMC Genomics (2011) 1.29

miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol (2011) 1.28

Clustering methods for microarray gene expression data. OMICS (2006) 1.28

Negative differential conductance and hot phonons in suspended nanotube molecular wires. Phys Rev Lett (2005) 1.28

Stress hormone and male reproductive function. Cell Tissue Res (2005) 1.27

PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol (2004) 1.27

Structural insights into the bactericidal mechanism of human peptidoglycan recognition proteins. Proc Natl Acad Sci U S A (2007) 1.27

The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J Immunol (2010) 1.26

MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol (2009) 1.26

Fluorogenic click reaction. Chem Soc Rev (2009) 1.26

Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines). CMAJ (2003) 1.25

Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice. CMAJ (2003) 1.25

Transmission ecology of Echinococcus multilocularis: what are the ranges of parasite stability among various host communities in China? Parasitol Int (2005) 1.25

Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. Carcinogenesis (2012) 1.25

Estimated effects of projected climate change on the basic reproductive number of the Lyme disease vector Ixodes scapularis. Environ Health Perspect (2014) 1.24

Extensive chromatin fragmentation improves enrichment of protein binding sites in chromatin immunoprecipitation experiments. Nucleic Acids Res (2008) 1.23

Head-to-tail peptide cyclodimerization by copper-catalyzed azide-alkyne cycloaddition. Angew Chem Int Ed Engl (2005) 1.23

Clustering of Ti on a C60 surface and its effect on hydrogen storage. J Am Chem Soc (2005) 1.23

Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Nat Immunol (2007) 1.22

Crystal structure of human peptidoglycan recognition protein S (PGRP-S) at 1.70 A resolution. J Mol Biol (2005) 1.22

PATJ regulates directional migration of mammalian epithelial cells. EMBO Rep (2007) 1.22